The hemostatic efficacy of platelet components prepared with pathogen inactivation

被引：8

作者：

Corash, Laurence ^{[1
,2
]}

机构：

[1] Cerus Corp, Med Affairs, Concord, CA USA

[2] Univ Calif San Francisco, Sch Med, Dept Lab Med, San Francisco, CA USA

来源：

TRANSFUSION | 2011年 / 51卷 / 06期

关键词：

SPRINT TRIAL; TRANSFUSIONS; SAFETY; IMPACT;

D O I：

10.1111/j.1537-2995.2011.03061.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1355 / 1356

页数：2

共 10 条

[1] Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period [J].

Cazenave, Jean-Pierre ;

Isola, Herve ;

Waller, Chantal ;

Mendel, Isabelle ;

Kientz, Daniel ;

Laforet, Michel ;

Raidot, Jean-Pierre ;

Kandel, Gerard ;

Wiesel, Marie-Louise ;

Corash, Laurence .

TRANSFUSION, 2011, 51 (03) :622-629

[2] Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction [J].

Kerkhoffs, Jean-Louis H. ;

van Putten, Wim L. J. ;

Novotny, Viera M. J. ;

Boekhorst, Peter A. W. Te ;

Schipperus, Martin R. ;

Zwaginga, Jaap Jan ;

van Pampus, Lizzy C. M. ;

de Greef, Georgine E. ;

Luten, Marleen ;

Huijgens, Peter C. ;

Brand, Anneke ;

van Rhenen, Dick J. .

BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (02) :209-217

[3] Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial [J].

McCullough, J ;

Vesole, DH ;

Benjamin, RJ ;

Slichter, SJ ;

Pineda, A ;

Snyder, E ;

Stadtmauer, EA ;

Lopez-Plaza, I ;

Coutre, S ;

Strauss, RG ;

Goodnough, LT ;

Fridey, JL ;

Raife, T ;

Cable, R ;

Murphy, S ;

Howard, F ;

Davis, K ;

Lin, JS ;

Metzel, P ;

Corash, L ;

Koutsoukos, A ;

Lin, L ;

Buchholz, DH ;

Conlan, MG .

BLOOD, 2004, 104 (05) :1534-1541

[4] Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use [J].

Osselaer, Jean Claude ;

Doyen, Chantal ;

Defoin, Laurence ;

Debry, Cecile ;

Goffaux, Maite ;

Messe, Nathalie ;

Van Hooydonk, Maryse ;

Bosly, Andre ;

Lin, Jin Sying ;

Lin, Lily ;

Corash, Laurence .

TRANSFUSION, 2009, 49 (07) :1412-1422

[5] The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia [J].

Rebulla, P ;

Finazzi, G ;

Marangoni, F ;

Avvisati, G ;

Gugliotta, L ;

Tognoni, G ;

Barbui, T ;

Mandelli, F ;

Sirchia, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (26) :1870-1875

[6] Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage [J].

Slichter, Sherrill J. ;

Kaufman, Richard M. ;

Assmann, Susan F. ;

McCullough, Jeffrey ;

Triulzi, Darrell J. ;

Strauss, Ronald G. ;

Gernsheimer, Terry B. ;

Ness, Paul M. ;

Brecher, Mark E. ;

Josephson, Cassandra D. ;

Konkle, Barbara A. ;

Woodson, Robert D. ;

Ortel, Thomas L. ;

Hillyer, Christopher D. ;

Skerrett, Donna L. ;

McCrae, Keith R. ;

Sloan, Steven R. ;

Uhl, Lynne ;

George, James N. ;

Aquino, Victor M. ;

Manno, Catherine S. ;

McFarland, Janice G. ;

Hess, John R. ;

Leissinger, Cindy ;

Granger, Suzanne ;

Exum, V. ;

Hendrix, D. ;

Ruys, N. ;

Werndli, J. ;

Koenig, K. ;

Turman, N. ;

Stublaski, J. ;

Lankiewicz, M. ;

Miller-Metcalfe, D. ;

Graminske, S. ;

Dora, R. ;

Heldke, S. ;

Divgi, A. B. ;

Boos, J. ;

Beekman, S. ;

Punzalan, R. ;

Neufeld, E. J. ;

Kang, T. ;

Hedstrom, J. ;

Harney, K. ;

Malynn, B. ;

Kelly, M. ;

Rowe, B. ;

Wallace, K. ;

Slate, S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (07) :600-613

[7] Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients [J].

Slichter, SJ ;

Davis, K ;

Enright, H ;

Braine, H ;

Gernsheimer, T ;

Kao, KJ ;

Kickler, T ;

Lee, E ;

McFarland, J ;

McCullough, J ;

Rodey, G ;

Schiffer, C ;

Woodson, R .

BLOOD, 2005, 105 (10) :4106-4114

[8] Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial [J].

Snyder, E ;

McCullough, J ;

Slichter, SJ ;

Strauss, RG ;

Lopez-Plaza, I ;

Lin, JS ;

Corash, L ;

Conlan, MG .

TRANSFUSION, 2005, 45 (12) :1864-1875

[9] Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets [J].

Vamvakas, Eleftherios C. .

TRANSFUSION, 2011, 51 (05) :1058-1071

[10] Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment:: the euroSPRITE trial [J].

van Rhenen, D ;

Gulliksson, H ;

Cazenave, JP ;

Pamphilon, D ;

Ljungman, P ;

Klüter, H ;

Vermeij, H ;

Kappers-Klunne, M ;

de Greef, G ;

Laforet, M ;

Lioure, B ;

Davis, K ;

Marblie, S ;

Mayaudon, V ;

Flament, J ;

Conlan, M ;

Lin, L ;

Metzel, P ;

Buchholz, B ;

Corash, L .

BLOOD, 2003, 101 (06) :2426-2433

← 1 →